RESTORE Act of 2019

Bill: 116-hr-4563
Sponsor: full_name: Rep. Fitzpatrick, Brian K. [R-PA-1]
Introduced: 2019-09-27
Policy area: Crime and Law Enforcement
Subjects: Administrative remedies

Congressional oversight

Crime prevention

Criminal investigation, prosecution, interrogation

Department of Justice

Drug trafficking and controlled substances

Fraud offenses and financial crimes

Health care coverage and access

Licensing and registrations

Medical education

Prescription drugs

Retail and wholesale trades
Latest action: action_date: 2019-10-28
text: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Summaries:
action_date: 2019-09-27
action_desc: Introduced in House
text: <p><b>Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2019 or the RESTORE Act of 2019</b></p> <p>This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. That act modified the standards that the Drug Enforcement Administration must apply when deciding whether to deny, revoke, or suspend the registration of a manufacturer, distributor, or dispenser of controlled substances (i.e., substances regulated under federal law based on their medical use and potential for dependence and abuse).</p>

tv_txt: I 116th CONGRESS 1st Session H. R. 4563 IN THE HOUSE OF REPRESENTATIVES September 27, 2019 Mr. Fitzpatrick (for himself and Ms. Kuster of New Hampshire ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To repeal Public Law 114–145 to ensure that the Drug Enforcement Administration has the authority to carry out needed enforcement actions for drug diversion control investigations and operations to combat the opioid epidemic, and for other purposes.

1. Short title This Act may be cited as the Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2019 or the RESTORE Act of 2019 . 2. Restoring DEA’s authority to carry out needed enforcement actions to combat drug diversion and the opioid epidemic (a) Repeal Public Law 114–145 (the Ensuring Patient Access and Effective Drug Enforcement Act of 2016) is hereby repealed. (b) Restoration of provisions (1) Effective as of the date of enactment of Public Law 114–145 , the provisions of section 304 of the Controlled Substances Act ( 21 U.S.C. 824 ) that were amended by Public Law 114–145 are hereby restored as if Public Law 114–145 had not been enacted into law. (2) Subsection (k) of section 303 of the Controlled Substances Act ( 21 U.S.C. 823(k) ), as added by Public Law 114–145 and redesignated by Public Law 115–83 , is hereby repealed.